Back
Structure Therapeutics, Inc. Stock Price Chart
The Next Gold Rush
DISCLOSURE: EnergyX's Regulation A offering has been qualified by the SEC. Before investing, carefully review the offering circular, including the risk factors. The offering circular is available at
Buy
84
GPCR
Structure Therapeutics, Inc.
Last Price:
$77.86
Seasonality Move:
-21.79%
7 Day Trial
ALL ACCESS PASS
$
7
Meet America's Newest $1B Unicorn
DISCLOSURE: EnergyX's Regulation A offering has been qualified by the SEC. Before investing, carefully review the offering circular, including the risk factors. The offering circular is available at-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GPCR is experiencing slight buying pressure.
Structure Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 68.09 | Buy |
| 20-day SMA: | 66.67 | Buy |
| 50-day SMA: | 49.92 | Buy |
| 200-day SMA: | 28.92 | Buy |
| 8-day EMA: | 69.59 | Buy |
| 20-day EMA: | 64.84 | Buy |
| 50-day EMA: | 53.42 | Buy |
| 200-day EMA: | 35.43 | Buy |
Structure Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 5.86 | Buy |
| Relative Strength Index (14 RSI): | 72.08 | Buy |
| Chaikin Money Flow: | 871233 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (58.33 - 72.95) | Buy |
| Bollinger Bands (100): | (19.6 - 54.7) | Buy |
Structure Therapeutics, Inc. Technical Analysis
| Dec 29 | Dec 30 | Dec 31 | Jan 5 | Jan 6 | Jan 7 | Jan 8 | Jan 9 | Jan 12 | Jan 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 29 | 30 | 31 | 05 | 06 | 07 | 08 | 09 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Structure Therapeutics, Inc. Stock
Is Structure Therapeutics, Inc. Stock a Buy?
-
Structure Therapeutics, Inc. share price is 77.92 while GPCR 8-day simple moving average is 68.09, which is a Buy signal.
-
The stock price of GPCR is 77.92 while Structure Therapeutics, Inc. 20-day SMA is 66.67, which makes it a Buy.
-
Structure Therapeutics, Inc. 50-day simple moving average is 49.92 while GPCR share price is 77.92, making it a Buy technically.
-
GPCR stock price is 77.92 and Structure Therapeutics, Inc. 200-day simple moving average is 28.92, creating a Buy signal.
GPCR Technical Analysis vs Fundamental Analysis
Buy
84
Structure Therapeutics, Inc. (GPCR)
is a Buy
Is Structure Therapeutics, Inc. a Buy or a Sell?
-
Structure Therapeutics, Inc. stock is rated a BuyThe current Structure Therapeutics, Inc. [GPCR] share price is $77.92. The Score for GPCR is 84, which is 68% above its historic median score of 50, and infers lower risk than normal.
Structure Therapeutics, Inc. Stock Info
Market Cap:
4.5B
Price in USD:
77.92
Share Volume:
3.4M
Structure Therapeutics, Inc. 52-Week Range
52-Week High:
94.90
52-Week Low:
13.22
Buy
84
Structure Therapeutics, Inc. (GPCR)
is a Buy
Structure Therapeutics, Inc. Share Price Forecast
-
What is the Structure Therapeutics, Inc. stock price today?The Structure Therapeutics, Inc. stock price is 77.92 USD today.
-
Will GPCR stock go up or go down?Structure Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Structure Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Structure Therapeutics, Inc. is not overvalued.
Is Structure Therapeutics, Inc. Stock a Buy?
-
Structure Therapeutics, Inc. share price is 77.92 while GPCR 8-day exponential moving average is 69.59, which is a Buy signal.
-
The stock price of GPCR is 77.92 while Structure Therapeutics, Inc. 20-day EMA is 64.84, which makes it a Buy.
-
Structure Therapeutics, Inc. 50-day exponential moving average is 53.42 while GPCR share price is 77.92, making it a Buy technically.
-
GPCR stock price is 77.92 and Structure Therapeutics, Inc. 200-day simple moving average is 35.43, creating a Buy signal.
Fundamental Analysis of Structure Therapeutics, Inc.
Is Structure Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.09 per share, and a decrease next year of $0.34 per share.
Technical Analysis of Structure Therapeutics, Inc.
Should I short Structure Therapeutics, Inc. stock?
-
GPCR Moving Average Covergence Divergence (MACD) indicator is 5.86, suggesting Structure Therapeutics, Inc. is a Buy
-
Structure Therapeutics, Inc. Relative Strength Index (RSI) is 72.08, which suggest Structure Therapeutics, Inc. is overbought
-
The Bollinger Bands (25) for Structure Therapeutics, Inc. is (58.33 - 72.95), which suggest Structure Therapeutics, Inc. is a Buy
-
The Bollinger Bands (100) for Structure Therapeutics, Inc. is (19.6 - 54.7), which suggest Structure Therapeutics, Inc. is a Buy
* Structure Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.